Intuitive Surgical stock slips again as 2026 da Vinci outlook hangs over ISRG ahead of earnings
Intuitive Surgical shares fell 0.9% to $536.49 in early New York trading Friday after the company’s 2026 da Vinci procedure-growth forecast missed some investor expectations. The company reported unaudited Q4 revenue of $2.87 billion, up 19%, and projected 2026 da Vinci procedure growth of 13% to 15%. Investors await more detail at the Jan. 22 earnings call.